Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ferric Maltol in Iron Deficiency Anemia with Inflammatory Bowel Disease
NCT07739368Phase 3Completed
- Sponsor
- Jiangsu Aosaikang Pharmaceutical Co., Ltd.
- Start
- Sep 2021
- Primary completion
- Feb 2025
- Countries
- 1
01
Overview
A Phase 3 trial of ferric maltol in iron deficiency anemia (IDA), sponsored by Jiangsu Aosaikang Pharmaceutical Co., Ltd.. Started Sep 2021; status: completed.
02
Drugs
ferric maltol
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT07739368.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07739368.